Cargando…
A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668455/ https://www.ncbi.nlm.nih.gov/pubmed/31366914 http://dx.doi.org/10.1038/s41408-019-0217-5 |
| _version_ | 1783440220980510720 |
|---|---|
| author | Spencer, Andrew Walker, Patricia Asvadi, Parisa Campbell, Douglas H. Reed, Kate Herbert, Ben R. Breen, Edmond J. Copeman, Michael C. Dunn, Rosanne D. |
| author_facet | Spencer, Andrew Walker, Patricia Asvadi, Parisa Campbell, Douglas H. Reed, Kate Herbert, Ben R. Breen, Edmond J. Copeman, Michael C. Dunn, Rosanne D. |
| author_sort | Spencer, Andrew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6668455 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66684552019-08-01 A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma Spencer, Andrew Walker, Patricia Asvadi, Parisa Campbell, Douglas H. Reed, Kate Herbert, Ben R. Breen, Edmond J. Copeman, Michael C. Dunn, Rosanne D. Blood Cancer J Correspondence Nature Publishing Group UK 2019-07-31 /pmc/articles/PMC6668455/ /pubmed/31366914 http://dx.doi.org/10.1038/s41408-019-0217-5 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Spencer, Andrew Walker, Patricia Asvadi, Parisa Campbell, Douglas H. Reed, Kate Herbert, Ben R. Breen, Edmond J. Copeman, Michael C. Dunn, Rosanne D. A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma |
| title | A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma |
| title_full | A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma |
| title_fullStr | A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma |
| title_full_unstemmed | A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma |
| title_short | A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma |
| title_sort | preliminary study of the anti-κ myeloma antigen monoclonal antibody kappamab (mdx-1097) in pretreated patients with κ-restricted multiple myeloma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668455/ https://www.ncbi.nlm.nih.gov/pubmed/31366914 http://dx.doi.org/10.1038/s41408-019-0217-5 |
| work_keys_str_mv | AT spencerandrew apreliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT walkerpatricia apreliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT asvadiparisa apreliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT campbelldouglash apreliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT reedkate apreliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT herbertbenr apreliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT breenedmondj apreliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT copemanmichaelc apreliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT dunnrosanned apreliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT spencerandrew preliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT walkerpatricia preliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT asvadiparisa preliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT campbelldouglash preliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT reedkate preliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT herbertbenr preliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT breenedmondj preliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT copemanmichaelc preliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma AT dunnrosanned preliminarystudyoftheantikmyelomaantigenmonoclonalantibodykappamabmdx1097inpretreatedpatientswithkrestrictedmultiplemyeloma |